FinlandOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,762 out of 249,410 Researchers
Data For The Year: 2026
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 47,738 | 43,784 |
| Total Cites | 10,472 | 12,394 |
| H-index | 50 | 57 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 675 | 775 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 983 | 1,146 |
| Number of Single+First+Last Authored Papers | 147 | 147 |
| Total Cites to Single+First+Last Authored Papers | 5,680 | 6,667 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,904 | 9,555 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.30 |
| Self-Citation Percentage |
15.51%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,683 out of 210,400 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43,544 | 39,115 |
| Total Cites | 8,839 | 10,609 |
| H-index | 43 | 50 |
| Hm-index | 19 | 21 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 652 | 751 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 947 | 1,109 |
| Number of Single+First+Last Authored Papers | 144 | 144 |
| Total Cites to Single+First+Last Authored Papers | 4,883 | 5,822 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,451 | 8,026 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.32 |
| Self-Citation Percentage |
16.68%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,599 out of 199,278 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40,888 | 37,301 |
| Total Cites | 8,191 | 9,899 |
| H-index | 41 | 48 |
| Hm-index | 19 | 21 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 647 | 746 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 938 | 1,100 |
| Number of Single+First+Last Authored Papers | 144 | 144 |
| Total Cites to Single+First+Last Authored Papers | 4,578 | 5,506 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,860 | 7,401 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.34 |
| Self-Citation Percentage |
17.25%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,589 out of 192,021 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40,956 | 36,517 |
| Total Cites | 7,860 | 9,531 |
| H-index | 40 | 47 |
| Hm-index | 18 | 20 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 636 | 735 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 919 | 1,081 |
| Number of Single+First+Last Authored Papers | 143 | 143 |
| Total Cites to Single+First+Last Authored Papers | 4,409 | 5,331 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,583 | 7,101 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.34 |
| Self-Citation Percentage |
17.53%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.